NCT04467736

Brief Summary

After tooth extraction, shrinkage of the bone is expected after 6 months. These changes may hamper dental implant placement and compromise soft tissue aesthetics. Alveolar Ridge Preservation (ARP) includes application of bovine-derived deproteinized bone particles in the extraction site. This technique is widely performed and drastically limits aforementioned volumetric changes. The amount of bone preservation following ARP is affected by the soft tissue barrier. In an open healing situation, it takes about 4 weeks to have complete soft tissue closure. Faster soft tissue closure could optimize the amount of bone preservation with obvious benefits for implant placement and aesthetics. Recent presentations showed the application of hyaluronic acid after ARP. However, no evidence can be found in the literature. This study aims to evaluate the wound healing potential of hyaluronic acid following ARP, as this has never been performed, yet seems promising from a biological point of view.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 8, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 13, 2020

Completed
19 days until next milestone

Study Start

First participant enrolled

August 1, 2020

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2021

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 24, 2022

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

11 months

First QC Date

July 8, 2020

Last Update Submit

September 5, 2024

Conditions

Keywords

Alveolar ridge preservationHyaluronic acidWound healing

Outcome Measures

Primary Outcomes (1)

  • Wound reduction

    performed by measuring the maximum mesio-distal and bucco-oral dimension of the wound immediately after ARP and after 21 days

    Week 3 after ARP

Secondary Outcomes (9)

  • Compliance

    Week 1

  • Number of painkillers consumed

    Week 1

  • VAS pain

    Week 1

  • VAS swelling

    Week 1

  • Bleeding

    Week 1

  • +4 more secondary outcomes

Study Arms (2)

Control

NO INTERVENTION

No further treatment after alveolar ridge preservation

Test

ACTIVE COMPARATOR

In case the test group comes out, instructions for the daily application of hyaluronic acid (Gengigel Forte©) will be given. Hyaluronic acid will be administered by the patient 3 times per day during 7 days.

Device: Gengigel Forte©

Interventions

Gengigel (hyaluronic acid) will be administered by the patient 3 times per day during 7 days following alveolar ridge preservation

Test

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least 18 years old;
  • Good oral hygiene defined as a full-mouth plaque score ≤25%;
  • One or two neighboring teeth;
  • Need for ARP after tooth extraction with \>50% buccal bone still present

You may not qualify if:

  • Systemic diseases;
  • Smoking;
  • (History) of periodontal disease;
  • Untreated caries lesions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital

Ghent, 9000, Belgium

Location

Related Publications (14)

  • Afat IM, Akdogan ET, Gonul O. Effects of Leukocyte- and Platelet-Rich Fibrin Alone and Combined With Hyaluronic Acid on Pain, Edema, and Trismus After Surgical Extraction of Impacted Mandibular Third Molars. J Oral Maxillofac Surg. 2018 May;76(5):926-932. doi: 10.1016/j.joms.2017.12.005. Epub 2017 Dec 13.

    PMID: 29304325BACKGROUND
  • Afat IM, Akdogan ET, Gonul O. Effects of leukocyte- and platelet-rich fibrin alone and combined with hyaluronic acid on early soft tissue healing after surgical extraction of impacted mandibular third molars: A prospective clinical study. J Craniomaxillofac Surg. 2019 Feb;47(2):280-286. doi: 10.1016/j.jcms.2018.11.023. Epub 2018 Dec 3.

    PMID: 30579747BACKGROUND
  • Cosyn J, Cleymaet R, De Bruyn H. Predictors of Alveolar Process Remodeling Following Ridge Preservation in High-Risk Patients. Clin Implant Dent Relat Res. 2016 Apr;18(2):226-33. doi: 10.1111/cid.12249. Epub 2014 Jul 17.

    PMID: 25041378BACKGROUND
  • Eskandarinia A, Kefayat A, Gharakhloo M, Agheb M, Khodabakhshi D, Khorshidi M, Sheikhmoradi V, Rafienia M, Salehi H. A propolis enriched polyurethane-hyaluronic acid nanofibrous wound dressing with remarkable antibacterial and wound healing activities. Int J Biol Macromol. 2020 Apr 15;149:467-476. doi: 10.1016/j.ijbiomac.2020.01.255. Epub 2020 Jan 27.

    PMID: 32001284BACKGROUND
  • Hammerle CH, Araujo MG, Simion M; Osteology Consensus Group 2011. Evidence-based knowledge on the biology and treatment of extraction sockets. Clin Oral Implants Res. 2012 Feb;23 Suppl 5:80-2. doi: 10.1111/j.1600-0501.2011.02370.x.

    PMID: 22211307BACKGROUND
  • Litwiniuk M, Krejner A, Speyrer MS, Gauto AR, Grzela T. Hyaluronic Acid in Inflammation and Tissue Regeneration. Wounds. 2016 Mar;28(3):78-88.

    PMID: 26978861BACKGROUND
  • Neuman MG, Nanau RM, Oruna-Sanchez L, Coto G. Hyaluronic acid and wound healing. J Pharm Pharm Sci. 2015;18(1):53-60. doi: 10.18433/j3k89d.

    PMID: 25877441BACKGROUND
  • Seyssens L, Eghbali A, Christiaens V, De Bruyckere T, Doornewaard R, Cosyn J. A one-year prospective study on alveolar ridge preservation using collagen-enriched deproteinized bovine bone mineral and saddle connective tissue graft: A cone beam computed tomography analysis. Clin Implant Dent Relat Res. 2019 Oct;21(5):853-861. doi: 10.1111/cid.12843. Epub 2019 Aug 28.

    PMID: 31456345BACKGROUND
  • Tan WL, Wong TL, Wong MC, Lang NP. A systematic review of post-extractional alveolar hard and soft tissue dimensional changes in humans. Clin Oral Implants Res. 2012 Feb;23 Suppl 5:1-21. doi: 10.1111/j.1600-0501.2011.02375.x.

    PMID: 22211303BACKGROUND
  • Van der Weijden F, Dell'Acqua F, Slot DE. Alveolar bone dimensional changes of post-extraction sockets in humans: a systematic review. J Clin Periodontol. 2009 Dec;36(12):1048-58. doi: 10.1111/j.1600-051X.2009.01482.x.

    PMID: 19929956BACKGROUND
  • Wessels R, De Roose S, De Bruyckere T, Eghbali A, Jacquet W, De Rouck T, Cosyn J. The Mucosal Scarring Index: reliability of a new composite index for assessing scarring following oral surgery. Clin Oral Investig. 2019 Mar;23(3):1209-1215. doi: 10.1007/s00784-018-2535-6. Epub 2018 Jul 3.

    PMID: 29971512BACKGROUND
  • Yildirim S, Ozener HO, Dogan B, Kuru B. Effect of topically applied hyaluronic acid on pain and palatal epithelial wound healing: An examiner-masked, randomized, controlled clinical trial. J Periodontol. 2018 Jan;89(1):36-45. doi: 10.1902/jop.2017.170105.

    PMID: 28914592BACKGROUND
  • Zeltner M, Jung RE, Hammerle CH, Husler J, Thoma DS. Randomized controlled clinical study comparing a volume-stable collagen matrix to autogenous connective tissue grafts for soft tissue augmentation at implant sites: linear volumetric soft tissue changes up to 3 months. J Clin Periodontol. 2017 Apr;44(4):446-453. doi: 10.1111/jcpe.12697. Epub 2017 Feb 11.

    PMID: 28107560BACKGROUND
  • Eeckhout C, Ackerman J, Glibert M, Cosyn J. A randomized controlled trial evaluating hyaluronic acid gel as wound healing agent in alveolar ridge preservation. J Clin Periodontol. 2022 Mar;49(3):280-291. doi: 10.1111/jcpe.13589. Epub 2021 Dec 30.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Patients will be randomly allocated to the 'test group (Hyaluronic acid)' or the 'control group (No hyaluronic acid). An equal number of sealed envelopes will be prepared internally labelled as 'test group' or 'control group'. Just after alveolar ridge preservation, a sealed envelope will be randomly selected and opened to reveal further treatment. The measuring investigator will not be involved in the treatment of any of the patients and will be blinded to allow unbiased registrations.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized clinical trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 8, 2020

First Posted

July 13, 2020

Study Start

August 1, 2020

Primary Completion

June 30, 2021

Study Completion

January 24, 2022

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations